Vaccine Refusal: A Major, Underestimated Obstacle for the Poliomyelitis Eradication Initiative.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
05 07 2023
Historique:
received: 09 03 2023
accepted: 12 04 2023
pmc-release: 01 07 2024
medline: 7 7 2023
pubmed: 16 5 2023
entrez: 15 5 2023
Statut: epublish

Résumé

In 1988, the WHO launched the Global Poliomyelitis Eradication Initiative with the goal of eradication by 2000. Not only has this goal, which has been repeatedly postponed, still not been achieved, but while the wild polio virus is still endemic in two Asian countries, a new epidemic caused by a vaccine-derived virus is spreading and is now affecting numerous developing and industrialized countries, including the United Kingdom and the United States. In addition to biological explanations for the failure of eradication, vaccination refusal by communities in mainly two regions of Africa and Asia has prevented mass vaccination campaigns from achieving their immunization coverage targets. The way these campaigns have been deployed has contributed to mistrust and hostility. The negative reactions of some communities, expressed from the first vaccination campaigns, were belatedly considered, which gave time for rumors to flourish and settle permanently. This failure underscores the importance of taking into account, before any vaccination campaign begins, the "health culture" of target populations-meaning their representations of the vaccines and the health authorities that promote vaccination, as well as their knowledge, fears, and hopes.

Identifiants

pubmed: 37188348
doi: 10.4269/ajtmh.23-0154
pii: tpmd230154
pmc: PMC10323996
doi:

Substances chimiques

Poliovirus Vaccine, Oral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6-9

Références

Lancet Infect Dis. 2015 Oct;15(10):1183-1192
pubmed: 26179316
Soc Sci Med. 2006 Oct;63(7):1857-69
pubmed: 16765498
PLoS Med. 2007 Mar;4(3):e73
pubmed: 17388657
Stud Fam Plann. 1996 May-Jun;27(3):127-36
pubmed: 8829295
Lancet. 2022 Oct 8;400(10359):1191
pubmed: 36183702
Risk Anal. 2006 Dec;26(6):1441-8
pubmed: 17184391
Vaccine. 2021 Jan 15;39(3):480-486
pubmed: 33358031
BMC Public Health. 2012 Jan 25;12:80
pubmed: 22276600
Science. 2006 Nov 17;314(5802):1150-3
pubmed: 17110580
JAMA. 2010 Jan 20;303(3):271-2
pubmed: 20085957
Lancet Glob Health. 2021 Aug;9(8):e1172-e1175
pubmed: 34118192
Vaccines (Basel). 2022 Dec 28;11(1):
pubmed: 36679915
Lancet Infect Dis. 2022 Feb;22(2):284-294
pubmed: 34648733
JAMA. 1987 Mar 13;257(10):1335-40
pubmed: 3029445
Nat Rev Microbiol. 2004 Jun;2(6):473-82
pubmed: 15152203
BMC Public Health. 2020 Dec 18;20(Suppl 4):1807
pubmed: 33339529
EClinicalMedicine. 2022 Jun 25;50:101508
pubmed: 35784443

Auteurs

Bernard Seytre (B)

bnscommunication, Lomé, Togo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH